Smitha Neerukonda

Smitha Neerukonda practices at Cheyenne Regional Medical Center in Cheyenne, Wyoming, part of Laramie County Shooting Sports Complex.

Smitha Neerukonda's NPI, 1669835013, was assigned on April 3, 2016. Smitha Neerukonda graduated from Tulane University School of Medicine in 2016. Smitha Neerukonda holds Colorado license DR.0068556.

Smitha Neerukonda's primary practice is Cheyenne Regional Medical Center, at 214 East 23rd Street, Cheyenne, WY 82001 in Laramie County. The practice phone is (307) 633-2273.

Smitha Neerukonda's primary practice is Cheyenne Regional Medical Center in Cheyenne, Wyoming, part of Laramie County Shooting Sports Complex. Smitha Neerukonda is also affiliated with Community Hospital. The medical group on file is Cheyenne Regional Medical Group. Dmand AI also links Smitha Neerukonda to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Smitha Neerukonda practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Smitha Neerukonda's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Smitha Neerukonda is licensed in Colorado.

CMS data shows 622 Medicare services from Smitha Neerukonda across 12 procedure codes in 2024, for 406 Medicare patients. Medicare paid $64,046 for them.

CMS counts 406 Medicare patients who saw Smitha Neerukonda in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Smitha Neerukonda's median patient age at 72, with 52% women.

In 2024, Smitha Neerukonda wrote 1,625 Medicare Part D claims for 313 patients. 89% of them were for generic drugs. CMS names the drug for 1,490 of them, across 25 drugs with 11 or more claims each, at $144,879 in total drug cost. In 2023, CMS named 501 claims across 17 drugs.

Smitha Neerukonda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Smitha Neerukonda in 2014. Smitha Neerukonda's most frequent co-authors are Uri Elkayam, MD, Prerna Kumar, MD and Salima Qamruddin, MD.

CMS Open Payments shows 85 general payments to Smitha Neerukonda from 21 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $1,247.

Smitha Neerukonda graduated from Tulane University School of Medicine in 2016.